Tester Construction Gives
Public records show a registered, tax-exempt organization in good standing.
What it says it does
TCGIVES WAS BORN IN MEMORY OF KATHLEEN K. SCHOEMAKER WHO LOST HER BATTLE TO PANCREATIC CANCER IN 2006. TCGIVES WILL RAISE MONEY TO PROMOTE PROGRESS IN THE DIAGNOSIS AND TREATMENT OF PANCREATIC CANCER IN HONOR OF KATHLEEN. EVERY YEAR, MORE THAN 66,440 AMERICANS ARE DIAGNOSED WITH PANCREATIC CANCER, THE THIRD-LEADING CAUSE OF CANCER DEATH IN THE COUNTRY. THROUGH FUNDRAISING EFFORTS TCGIVES, IN PARTNERSHIP WITH JEFFERSON'S SIDNEY KIMMEL CANCER CENTER, WANT TO GIVE THE GIFT OF HOPE TO PATIENTS AND FAMILIES MET WITH A DIAGNOSIS OF PANCREATIC CANCER.
- Income
- $285,398
- Spending
- $261,467
- Spent on programs
- 97%
- Reserves
- 1.2 months of spending
- Largest source of income
- fees for its services, 100%
- Employees
- 0
- Volunteers
- 2
Source: Form 990 for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Financial health
Good: 75 out of 100. Higher than 31% of charities in its peer group (medical research, $250k to $1m).
Reserves
10 of 35Spendable reserves would cover 1.2 months of spending.
Debt
20 of 20It owes 0% of what it owns.
Living within its means
15 of 15Income exceeded spending by 8% of income.
Income trend
15 of 15Income rose 642% on the year before.
Spending floor
15 of 1597% of spending went to programs.
Source: Form 990 for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Governance
Fair: 60 out of 100. Higher than 32% of charities in its peer group (medical research, $250k to $1m).
Independent board
5 of 250 of 5 voting board members are independent.
Conflict of interest policy
15 of 15Has a written conflict of interest policy.
Whistleblower policy
0 of 8Reports no written whistleblower policy.
Record keeping policy
0 of 7Reports no written policy on keeping and destroying records.
Board minutes
5 of 5Keeps minutes of board meetings.
Board sees the tax return
10 of 10Gave the board a copy of this return before filing it.
Independent check of accounts
12 of 15Its accounts were reviewed or compiled by an independent accountant, but not audited.
No reported misuse
10 of 10Reports no diversion of assets, excess benefits or loans to insiders.
Source: Form 990 for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Impact evidence
Describes programs. Its tax return describes what it does but we have found no measurable results in it.
Programs described in its return (1)
- $253,002 spent. WE ARE, AND CONTINUE TO BE, OVERWHELMED BY DR. YEO'S TEAMS DEDICATION TO THEIR PATIENTS, THEIR FOCUS ON IMPROVING THEIR PATIENTS QUALITY OF LIFE, AND THEIR COMMITMENT TO FINDING A CURE TO PANCREATIC CANCER. TCG GIVES HAS PARTNERED WITH DR. YEO'S TEAM AND JEFFERSON'S SIDNEY KIMMEL CANCER CENTER THAT WE MAY ADVANCE TREATMENT OPTIONS FOR THOSE DIAGNOSED WITH PANCREATIC CANCER. THIS INITIATIVE SEEKS TO IDENTIFY BIOMARKERS IN EARLY STAGE TUMORS, WHICH CAN IN TURN INFORM TUMOR-SPECIFIC TREATMENT AND POTENTIALLY PREDICT DRUG RESPONSE AND DISEASE RECURRENCE. BIOMARKER TESTING IS NOT COVERED UNDER INSURANCE AND RELIES COMPLETELY ON DONATIONS FROM ORGANIZATIONS LIKE TCG GIVES. THIS RESEARCH WILL ADVANCE PANCREATIC CANCER TREATMENT AND IMPROVE SURVIVAL RATES, ULTIMATELY PROVIDING THE BIGGEST GIFT TO THOSE FACED WITH PANCREATIC CANCER: HOPE. JEFFERSON HAS THE TOP PANCREATIC SURGICAL AND RESEARCH TEAM IN THE COUNTRY, LED BY DR. CHARLES YEO. TCG GIVES PROCEEDS WILL GO DIRECTLY TO DR. YEO'S MOLECULAR PROFILING INITIATIVE. ONE OF THE GOALS OF JEFFERSONS' RESEARCH IS TO PROFILE EACH PATIENT'S TUMOR. AS DESCRIBED BY DR. YEO. "BY PROFILING EACH PATIENT'S TUMOR, WE CAN BETTER TARGET THEIR SPECIFIC CANCER. THIS IS THE DIRECTION OF MODERN, PERSONALIZED ONCOLOGIC CARE, NOT TO MENTION ADVANCES OUR RESEARCH". THERE IS LIMITED FUNDING FROM NIH AND THE AMERICAN CANCER SOCIETY AND THEREFOR JEFFERSON'S RESEARCH TEAM RELIES ON PHILANTHROPY TO CONTINUE TO CREATE FORWARD MOVEMENT IN TREATING THIS DISEASE.
Source: Form 990 for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Legitimacy checks
Is it registered with the IRS? Passed.
Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
Has the IRS revoked its tax-exempt status? Passed.
Not on the IRS automatic revocation list.
Source: Automatic revocation of exemption list, Internal Revenue Service, file dated October 13, 2026.
Are donations tax-deductible? Passed.
On the IRS list of organizations eligible to receive tax-deductible contributions.
Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated October 13, 2026.
Is it keeping up with its IRS filings? Passed.
Most recent return on file covers the year ending December 2025.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
How long has it been tax-exempt? Passed.
Recognized by the IRS since September 2022.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
Is it in good standing with state regulators? Passed.
Not on California's list of charities barred from soliciting. Other states are not yet checked.
Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated October 21, 2026.
Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.